semaglutide liver fat reduction CDSCO Clears Wegovy for MASH — India's First GLP-1 Approval for Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Pharmacotherapy for Non-alcoholic Fatty Liver

This is particularly beneficial for individuals struggling to achieve weight loss through diet and exercise alone

By stimulating the body's natural fat-burning processes, both peptides can enhance the effectiveness of diet and exercise programs aimed at reducing body fat and preserving lean muscle mass

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes variants in antioxidant and detoxification pathways including GCLC, GCLM, and GST genes

Glutathione Booster Shot Elevate Your Wellness Journey with Our Glutathione shot Experience the power of Glutathione with our booster shot

I was looking for something that could work for my body, especially during busy work periods when energy tends to be low